Search results
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 11 hours agoA panel of independent advisors to the Food and Drug Administration on Monday recommended Eli Lilly'...
Alzheimer’s drug from Eli Lilly wins backing of FDA committee
Washington Post· 10 hours agoMuch of the committee’s discussion focused on the safety of the drug, donanemab, which works by...
Alzheimer’s drug that can slow disease gets backing from FDA advisers
Chicago Tribune· 9 hours agoA closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on...
What's the difference between California's legislative public safety package and Prop 47 reform...
KCRA 3 Sacramento· 4 hours agoA major political fight over public safety in California is heating up as Democratic leaders attempt...
FDA advisors strongly back new Alzheimer’s drug, despite risks and limitations
WUSF 89.7· 12 hours agoAdvisors to the Food and Drug Administration have recommended unanimously that the agency approve...
Lilly Alzheimer’s drug gets unanimous backing of FDA panel
BioPharma Dive via Yahoo Finance· 14 hours agoARIA is quite often asymptomatic and is only identified via magnetic resonance imaging But at least...
Lilly's Alzheimer's drug faces delayed reckoning
Axios· 19 hours agoThe outlook for the latest experimental drug shown to delay Alzheimer's disease will come into focus Monday, when Food and Drug Administration ...
New Alzheimer’s treatment drug gets support from FDA advisory panel
WXYZ-TV Detroit· 10 hours agoIf approved by the FDA, it would become the second Alzheimer’s drug on the market. Alzheimer’s is an incurable disease that affects nearly ...
FDA panel approves Alzheimer's drug that can slow disease
WZZM 13 Grand Rapids· 10 hours agoA closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on...
FDA panel backs Eli Lilly’s Alzheimer’s drug
The Hill via Yahoo News· 8 hours agoA federal advisory panel on Monday voted in favor of recommending Eli Lilly’s new drug that is under consideration for its potential to slow the...